Vironix

Using AI to Detect Heart Failure

Company Information

Website:

https://vironix.ai/

Sector:

Healthcare Software

Location:

Austin, TX

Every 56 seconds, someone dies from cardiovascular disease. Chronic lung disease, meanwhile, is the world's third-leading cause of death.

As with many illnesses, the key to saving lives is to identify it and take action early. That’s what Vironix was designed to do.

This medical technology company makes Artificial Intelligence-enabled therapeutic monitoring software. This helps doctors catch and intervene early on dangerous health episodes.

Vironix’s patent-pending software outperforms the current standard of care in detecting/triaging heart failure, COPD, and asthma flareups. The company completed the 2021 Mass Challenge Accelerator and has Letters of Intent that represent a $150 million annual revenue opportunity.

Team Background

Sumanth Swaminathan - Co-Founder & CEO
Sriram Ramanathan - Co-Founder & Chief Technology Officer
Christopher Landon - Co-Founder & Medical Specialist
Raising
$1.07 million
Committed
$653K (61%)
Current Valuation
$14.90 million
Min. Investment
$250
Deal Type
Title III
(For all investors)
Offering Type
Equity
Finance History
  • $126K
    2022-04-01
    Unknown
    (Priced Round)
  • $250K
    2021-03-01
    Unknown
    (Convertible Note)
Learn more on WeFunder